Skip to content
healthcare.dev

Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet [Klor-Con]

RxNorm concept 1801295, branded drug (sbd). Prescribable name: Klor-Con M20 20 MEQ Extended Release Oral Tablet.

RxCUI
1801295
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/1801295 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Klor-Con M20 1500 MG Microencapsulated Extended Release Oral Tablet; Klor-Con M20 20 MEQ Microencapsulated Extended Release Oral Tablet; Microencapsulated K+ Chloride 20 MEQ Extended Release Oral Tablet [Klor-Con]; Microencapsulated Pot Chloride 20 MEQ Extended Release Oral Tablet [Klor-Con]

Related concepts

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1801295 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/1801295 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 1801295. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.